PHILADELPHIA, Aug. 18, 2025 (GLOBE NEWSWIRE) --

Flywire Corporation (NASDAQ: FLYW):

Grabar Law Office is investigating claims on behalf of shareholders of Flywire Corporation (NASDAQ: FLYW). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Flywire Corporation (NASDAQ: FLYW) shares prior to February 28, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/flywire-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. If, alternatively, you purchased your shares between February 28, 2024, and February 25, 2025, you can participate in the class action.

WHY? As alleged in a recently filed securities fraud class action complaint, Flywire Corporation (NASDAQ: FLYW), through certain of its officers, consistently touted the sustainability of Flywire’s revenue growth and financial condition, while downplaying the anticipated negative impacts of permit- and visa-related headwinds on the Company’s business. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the strength and sustainability of Flywire’s revenue growth was overstated; (ii) the negative impact that permit and visa-related restrictions were having and were likely to have on Flywire’s business was understated; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

WHAT YOU CAN DO NOW: If you purchased Flywire Corporation (NASDAQ: FLYW) shares prior to February 28, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/flywire-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. If, alternatively, you purchased your shares between February 28, 2024, and February 25, 2025, you can participate in the class action. $FLYW #Flywire

Ibotta, Inc. (NYSE: IBTA):

Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Ibotta, Inc. shares on or shortly after the company’s April 18, 2024 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/ibotta-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085, to learn more.

WHY? A federal securities fraud class action complaint alleges that statements made in Ibotta Inc’s (NYSE: IBTA) Registration Statement issued in connection with Ibotta’s April 18, 2024 initial public offering were false and/or misleading when made because they did not properly warn investors of the risks concerning Ibotta’s contract with The Kroger Co. Kroger’s contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta’s contract with Walmart, there was not a single warning of the at-will nature of Kroger’s contract.

WHAT YOU CAN DO NOW: If you purchased Ibotta, Inc. (NYSE: IBTA) shares on or shortly after the company’s April 18, 2024 IPO, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/ibotta-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.   #Ibotta $IBTA

iRobot Corporation (NASDAQ: IRBT):

Grabar Law Office is investigating claims on behalf of shareholders of iRobot Corporation (NASDAQ: IRBT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased iRobot Corporation (NASDAQ: IRBT) shares prior to January 29, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/irbt-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY? In August 2022, iRobot entered into a merger agreement with Amazon.com, Inc. (“Amazon”) pursuant to which Amazon would acquire iRobot for $61 per share in an all-cash transaction. However, in January 2024, Amazon and iRobot announced that they had mutually agreed to terminate the Amazon Acquisition, citing regulatory concerns. In the wake of the Amazon Acquisition’s termination, iRobot touted that it would be implementing an operational restructuring plan (the “Restructuring Plan”). The Restructuring Plan, according to the Company, would “enable [it] to chart a new strategic path for sustainable value creation.”

As alleged in a recently filed federal securities fraud class action complaint, iRobot Corporation (NASDAQ: IRBT), via certain of its officers, made materially false and misleading statements or failed to disclose material facts regarding the Company’s business, operations, and prospects. Including that: (i) iRobot overstated the extent to which the Restructuring Plan would help the Company maintain stability after the termination of the Amazon Acquisition; (ii) as a result, it was unlikely that iRobot would be able to profitably operate as a standalone company; (iii) accordingly, there was substantial doubt about the Company’s ability to continue as a going concern; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

WHAT YOU CAN DO NOW: If you purchased iRobot Corporation (NASDAQ: IRBT) shares prior to January 29, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/irbt-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.

$IRBT #iRobot

SelectQuote, Inc. (NYSE: SLQT):

Grabar Law Office is investigating claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased SelectQuote, Inc. (NYSE: SLQT) shares prior to September 9, 2020, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/selectquote-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085.

WHY? On May 1, 2025, at approximately noon eastern standard time, the U.S. Department of Justice (“DOJ”) filed a False Claims Act complaint against SelectQuote, alleging, “[f]rom 2016 through at least 2021” SelectQuote received “tens of millions of dollars” in “illegal kickbacks” from health insurance companies in exchange for steering Medicare beneficiaries to enroll in the insurers’ plans. Further, SelectQuote, in exchange for kickbacks, engaged in a conspiracy with major insurers to illegally discriminate against beneficiaries deemed to be less profitable, including those with disabilities. The DOJ concluded that SelectQuote made materially false claims by stating it offers “unbiased coverage comparisons” when in fact it “repeatedly directed Medicare beneficiaries to the plans offered by insurers that paid them the most money, regardless of the quality or suitability of the insurers’ plans.”

As alleged in a recently filed federal securities fraud class action complaint, SelectQuote, Inc. (NYSE: SLQT), through certain of its officers, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects including: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers’ plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors’ plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT YOU CAN DO NOW: If you purchased SelectQuote, Inc. (NYSE: SLQT) shares prior to September 9, 2020, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/selectquote-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. If, alternatively, you purchased your shares between September 9, 2020, and May 1, 2025, you can participate in the class action.
$SLQT #SLQT #SelectQuote

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel:  267-507-6085
Email: jgrabar@grabarlaw.com